title: DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.
abstract: BACKGROUND
  Recent data suggest that haplotypic variants of the DLG5 gene on 10q23 are associated with susceptibility to inflammatory bowel disease (IBD) in Germany. In view of the geographical differences in frequency of genetic markers and the absence of data in Central European patients, our aim was to determine the DLG5 R30Q variant in Hungarian IBD patients.
  
  
  METHODS
  We investigated 773 unrelated IBD patients (age 38.1 +/- 10.3 years; duration, 8.8 +/- 7.5 years; Crohn's disease [CD]: 639; male/female, 309/330; duration, 8.4 +/- 7.1 years; ulcerative colitis [UC]: 134; male/female, 63/71; duration, 10.6 +/- 8.9 years) and 150 healthy subjects. DLG5 R30Q and TLR4 D299G variants were tested by polymerase chain reaction/restriction fragment length polymorphism. DNA was screened for NOD2/CARD15 mutations by denaturing high-performance liquid chromatography. Detailed clinical phenotype was determined by reviewing the medical charts.
  
  
  RESULTS
  The frequency of the R30Q variant allele was not significantly different in IBD (22.0%), CD (20.8%), and UC (27.6%) patients compared with healthy control subjects (28.0%). In CD, the 113A variant allele was associated with steroid resistance (16.3% vs noncarriers, 7.6%; odds ratio [OR], 2.4; 95% CI 1.3-4.5; P = 0.013). In a logistic regression model carriage of DLG5 R30Q, perianal involvement and frequent relapses were independently associated with steroid resistance. No phenotype-genotype associations were found in UC patients, although a trend toward more extensive disease was observed in carriers of the variant allele (OR = 2.1; 95% CI 0.95-4.4; P = 0.07).
  
  
  CONCLUSIONS
  The present data strongly contrast previous data from Germany. DLG5 113A is not associated with disease susceptibility, but there was a tendency for this allele to confer resistance to steroids. Further studies are required to evaluate the significance of DLG5 in other populations from geographically diverse regions.
authors: First Department of Medicine, Semmelweis University, Budapest, Hungary. kislakpet@bel1.sote.hu
authors: Peter Laszlo
authors: PL
authors: Lakatos
authors: Simon
authors: S
authors: Fischer
authors: Karolien
authors: K
authors: Claes
authors: Agota
authors: A
authors: Kovacs
authors: Tamas
authors: T
authors: Molnar
authors: Istvan
authors: I
authors: Altorjay
authors: Pal
authors: P
authors: Demeter
authors: Zsolt
authors: Z
authors: Tulassay
authors: Karoly
authors: K
authors: Palatka
authors: Maria
authors: M
authors: Papp
authors: Paul
authors: P
authors: Rutgeerts
authors: Ferenc
authors: F
authors: Szalay
authors: Janos
authors: J
authors: Papp
authors: Severine
authors: S
authors: Vermeire
authors: Laszlo
authors: L
authors: Lakatos